期刊文献+
共找到154篇文章
< 1 2 8 >
每页显示 20 50 100
Role of non-steroidal anti-inflammatory drugs on intestinal permeability and nonalcoholic fatty liver disease 被引量:12
1
作者 erika utzeri paolo usai 《World Journal of Gastroenterology》 SCIE CAS 2017年第22期3954-3963,共10页
The use of non-steroidal anti-inflammatory drugs(NSAIDs) is widespread worldwide thanks to their analgesic, anti-inflammatory and antipyretic effects. However, even more attention is placed upon the recurrence of dige... The use of non-steroidal anti-inflammatory drugs(NSAIDs) is widespread worldwide thanks to their analgesic, anti-inflammatory and antipyretic effects. However, even more attention is placed upon the recurrence of digestive system complications in the course of their use. Recent data suggests that the complications of the lower gastro-intestinal tract may be as frequent and severe as those of the upper tract. NSAIDs enteropathy is due to enterohepatic recycling of the drugs resulting in a prolonged and repeated exposure of the intestinal mucosa to the compound and its metabolites. Thus leading to so-called topical effects, which, in turn, lead to an impairment of the intestinal barrier. This process determines bacterial translocation and toxic substances of intestinal origin in the portal circulation, leading to an endotoxaemia. This condition could determine a liver inflammatory response and might promote the development of nonalcoholic steatohepatitis, mostly in patients with risk factors such as obesity, metabolic syndrome and a high fat diet, which may induce a small intestinal bacterial overgrowth and dysbiosis. This alteration of gut microbiota may contribute to nonalcoholic fatty liver disease and its related disorders in two ways: firstly causing a malfunction of the tight junctions that play a critical role in the increase of intestinal permeability, and then secondly leading to the development of insulin resistance, body weight gain, lipogenesis, fibrogenesis and hepatic oxidative stress. 展开更多
关键词 Non-steroidal anti-inflammatory drugs Intestinal barrier Intestinal permeability Non-steroidal anti-inflammatory drugs - enteropathy Nonalcoholic fatty liver disease Nonalcoholic steatohepatitis MICROBIOTA Metabolic syndrome Proton pump inhibitors ENDOTOXAEMIA
下载PDF
The chaotic behavior among the oil prices, expectation of investors and stock returns: TAR-TR-GARCH copula and TAR-TR-TGARCH copula 被引量:3
2
作者 Melike Bildirici 《Petroleum Science》 SCIE CAS CSCD 2019年第1期217-228,共12页
This paper has two aims. The first one is to investigate the existence of chaotic structures in the oil prices, expectations of investors and stock returns by combining the Lyapunov exponent and Kolmogorov entropy, an... This paper has two aims. The first one is to investigate the existence of chaotic structures in the oil prices, expectations of investors and stock returns by combining the Lyapunov exponent and Kolmogorov entropy, and the second one is to analyze the dependence behavior of oil prices, expectations of investors and stock returns from January 02, 1990, to June06, 2017. Lyapunov exponents and Kolmogorov entropy determined that the oil price and the stock return series exhibited chaotic behavior. TAR-TR-GARCH and TAR-TR-TGARCH copula methods were applied to study the co-movement among the selected variables. The results showed significant evidence of nonlinear tail dependence between the volatility of the oil prices, the expectations of investors and the stock returns. Further, upper and lower tail dependence and comovement between the analyzed series could not be rejected. Moreover, the TAR-TR-GARCH and TAR-TR-TGARCH copula methods revealed that the volatility of oil price had crucial effects on the stock returns and on the expectations of investors in the long run. 展开更多
关键词 Oil price Expectations of INVESTORS - Stock returns Chaos Lyapunov exponent Kolmogorov entropy TAR-TR-GARCH and TAR-TR-TGARCH COPULA methods
下载PDF
Synthesis of (2S,4S)-2-Substituted-3- (3-Sulfanylpropanoyl)-6- Oxohexahydropyrimidine-4-Carboxylic Acids as Potential Antihypertensive Drugs
3
作者 Andrei Ershov Dmitry Nasledov +1 位作者 Igor Lagoda Valery Shamanin 《Journal of Materials Science and Chemical Engineering》 2015年第6期7-12,共6页
Proceeding from natural amino acid L-asparagine and commercially available aldehydes a stereoselective synthesis was developed of (2S,4S)-2-alkyl(aryl)-3-(3-sulfanylpropanoyl)-6-oxohexahy- dropyrimidine-4-carboxylic a... Proceeding from natural amino acid L-asparagine and commercially available aldehydes a stereoselective synthesis was developed of (2S,4S)-2-alkyl(aryl)-3-(3-sulfanylpropanoyl)-6-oxohexahy- dropyrimidine-4-carboxylic acids, potential antihypertensive drugs, inhibitors of the angiotensin converting enzyme. 展开更多
关键词 Synthesis of (2S 4S)-2-Substituted-3- (3-Sulfanylpropanoyl)-6- Oxohexahydropyrimidine-4-Carboxylic ACIDS AS POTENTIAL ANTIHYPERTENSIVE drugS
下载PDF
Association of KRAS Gene and microRNA-124-3p in Sporadic Colorectal Tumours
4
作者 Ozkan Bagci 《Journal of Biosciences and Medicines》 2024年第1期150-161,共12页
Aim: To reveal the exonic and 3’UTR sequences of KRAS, TP53, APC, BRAF, PIK3CA genes in sporadic colorectal tumors and to investigate the clinical relevance of 3’UTR variations in miRNA profiles. Methods: In the stu... Aim: To reveal the exonic and 3’UTR sequences of KRAS, TP53, APC, BRAF, PIK3CA genes in sporadic colorectal tumors and to investigate the clinical relevance of 3’UTR variations in miRNA profiles. Methods: In the study, the exonic and 3’UTR sequences of five genes in 12 sporadic colorectal tumors were extracted by next generation sequencing. In tumors with variation in the 3’UTR region, the changes caused by the variation in the miRNA binding profile were detected. The expression profile of these miRNAs in colorectal and other solid tumors compared to normal tissue was determined. Pathway analysis was performed to determine which signaling pathways miRNAs affect. Results: Case-10 in our study was wild type KRAS and received cetuximab treatment and developed drug resistance. In this case, it was concluded that the expression of KRAS increased and tumorigenesis progressed due to miRNAs that do not bind to this region due to variations in the 3’UTR region. Among these miRNAs, hsa-miR-124-3p was found to have decreased expression in colorectal tumors and to be associated with the ECM-receptor interaction pathway. Conclusion: Variations in the 3’UTR regions of genes critical in the process of carsinogenesis are associated with drug resistance and the process of tumorigenesis. 展开更多
关键词 Colorectal Tumours drug Resistance Personalised Medicine microRNA-124-3p
下载PDF
高效液相色谱-离子阱质谱法测定人血浆中的头孢拉定和青霉素G 被引量:7
5
作者 李晓东 尹利辉 冯玉飞 《分析测试学报》 CAS CSCD 北大核心 2004年第z1期8-11,共4页
  目前,β-内酰胺类抗生素在临床抗感染药物中占有十分突出的地位[1],但在近年来的药品不良反应报告中,抗生素类药物引起的不良反应也占据了很高的比例,其中有我国生活环境影响、感染性疾病多的客观因素,但病人用药盲目性大、医生用...   目前,β-内酰胺类抗生素在临床抗感染药物中占有十分突出的地位[1],但在近年来的药品不良反应报告中,抗生素类药物引起的不良反应也占据了很高的比例,其中有我国生活环境影响、感染性疾病多的客观因素,但病人用药盲目性大、医生用药随意性多的问题也普遍存在.…… 展开更多
关键词 HPLC - Ion trap mass spectrometry Penicillin G CEFRADINE drug concentration in plasma
下载PDF
我院2009-2011年门诊退药处方分析 被引量:3
6
作者 汤小明 温健中 蓝秀丹 《儿科药学杂志》 CAS 2013年第6期42-44,共3页
目的:统计我院2009-2011年门诊处方退药情况,分析医院药房在处方退药相关管理中存在的问题,提出加强管理的具体措施。方法:重新核对我院2009-2011年留存的765例门诊退药处方及原始处方,根据退药登记本按退药原因、处方数量、处方金额、... 目的:统计我院2009-2011年门诊处方退药情况,分析医院药房在处方退药相关管理中存在的问题,提出加强管理的具体措施。方法:重新核对我院2009-2011年留存的765例门诊退药处方及原始处方,根据退药登记本按退药原因、处方数量、处方金额、退药类别等进行整理和分析。结果:765例退药处方记录中,处方行为不规范和医患沟通不足导致退药328例(42.9%),出现不良反应退药184例(24.0%),收住院或转院退药87例(11.4%),计价收费错误退药54例(7.1%),其他原因退药112例(14.6%)。结论:医院应加强处方管理,规范处方行为,完善退药制度,以减少不必要的退药情况,确保妇女儿童用药安全。 展开更多
关键词 退药处方 统计分析 管理措施
下载PDF
环氧酶-2选择性抑制剂的再认识 被引量:2
7
作者 费允云 张奉春 《临床药物治疗杂志》 2008年第4期27-30,共4页
非甾体抗炎药(nonsteroidal anti-inflammatory drugs,NSAIDs)是一类具有抗炎与镇痛作用的药物,可以改善风湿性疾病的炎性症状并可缓解疼痛,是世界范围内使用最广泛的一类处方药。NSAIDs的作用机制是通过抑制环氧酶(cyclooxygena... 非甾体抗炎药(nonsteroidal anti-inflammatory drugs,NSAIDs)是一类具有抗炎与镇痛作用的药物,可以改善风湿性疾病的炎性症状并可缓解疼痛,是世界范围内使用最广泛的一类处方药。NSAIDs的作用机制是通过抑制环氧酶(cyclooxygenanse,COX)的活性进而阻断花生四烯酸转化为前列腺素、前列环素和血栓素A,(TXA,)而发挥其药理作用。但使用NSAIDs的过程中,尤其是长期、大量服用时可出现副作用,其中最常见的副作用是对胃肠道的损害。 展开更多
关键词 环氧酶-2 选择性抑制剂 非甾体抗炎药 NSAIDS drugS 风湿性疾病 花生四烯酸 镇痛作用
下载PDF
Effect of Nano - Titanium Dioxide with Different Antibiotics against Methicillin-Resistant Staphylococcus Aureus 被引量:5
8
作者 Aashis S. Roy Ameena Parveen +1 位作者 Anil R. Koppalkar M. V. N. Ambika Prasad 《Journal of Biomaterials and Nanobiotechnology》 2010年第1期37-41,共5页
The different investigation has been carried out on the biological activities of titanium dioxide nanoparticle but the effect of this nano product on the antibacterial activity of different antibiotics has not been ye... The different investigation has been carried out on the biological activities of titanium dioxide nanoparticle but the effect of this nano product on the antibacterial activity of different antibiotics has not been yet demonstrated. In this study the nano size TiO2 is synthesized using citric acid and alpha dextrose and the enhancement effect of TiO2 nanoparticle on the antibacterial activity of different antibiotics was evaluated against Methicillin-resistant Staphylococcus aureus (MRSA). During the present study, different concentrations of nano-scale TiO2 were tested to find out the best concentration that can have the most effective antibacterial property against the MRSA culture. Disk diffusion method was used to determine the antibacterial activity of these antibiotics in the absence and presence of sub inhibitory concentration of TiO2 nano particle. A clinical isolate of MRSA, isolated from Intensive Care Unit (ICU) was used as test strain. In the presence of sub-inhibitory concentration of TiO2 nanoparticle (20 μg/disc) the antibacterial activities of all antibiotics have been increased against test strain with minimum 2 mm to maximum 10mm. The highest increase in inhibitory zone for MRSA was observed against pencillin G and amikacin (each 10 mm). Conversely, in case of nalidixic acid, TiO2 nanoparticle showed a Synergic effect on the antibacterial activity of this antibiotic against test strain. These results signify that the TiO2 nanoparticle potentate the antimicrobial action of beta lactums, cephalosporins, aminoglycosides, glycopeptides, macrolids and lincosamides, tetracycline a possible utilization of nano compound in combination effect against MRSA. 展开更多
关键词 NANO - Titanium OXIDE S. AUREUS drug Resistance ANTIBACTERIAL Activity
下载PDF
On the feasibility of re-stimulation of shale wells 被引量:4
9
作者 Mohammad O.Eshkalak Umut Aybar Kamy Sepehrnoori 《Petroleum Science》 SCIE CAS CSCD 2015年第3期553-559,共7页
As a result of advances in horizontal comple- tions and multi-stage hydraulic fracturing, the U.S. has been able to economically develop several decades of worth of natural gas. However, a considerable concern has ris... As a result of advances in horizontal comple- tions and multi-stage hydraulic fracturing, the U.S. has been able to economically develop several decades of worth of natural gas. However, a considerable concern has risen on the economic viability of shale gas development for reasons associated with the fast production declines as well as recent down-turns of natural gas prices besides rises in the costs of new technologies. Therefore, an economic analysis is required to investigate the profitability of the re- fracturing treatment of unconventional gas resources. Net present value of cash flows and internal rate of return are calculated for a range of gas prices considering 20 years of natural gas production from a typical unconventional shale gas reservoir. A systematic comparison is then accom- plished for three scenarios: (1) re-fracturing versus no re- fracturing, (2) combination of re-fracturing and drilling new wells, and (3) time-dependent re-fracturing treatment. Further, this paper incorporates the cost of re-fracturing treatment, the cost of drilling a new horizontal well, the water treatment cost, as well as the current and future price of natural gas in the model. The findings of this work would help the future re-stimulation development plans of the emerging unconventional shale gas plays. 展开更多
关键词 Economic analysis - Unconventional shaleassets Hydraulic re-fracturing - Net present value Internal rate of return
下载PDF
NAG-1抗肿瘤的机制及其表达调控
10
作者 王静 王春晖 《华西医学》 CAS 2008年第4期926-927,共2页
关键词 抗肿瘤机制 TGF-Β超家族 表达调控 转化生长因子-Β 非甾体类消炎药 促凋亡 活化基因 drug
下载PDF
EP4 agonist alleviates indomethacin-induced gastric lesions and promotes chronic gastric ulcer healing 被引量:1
11
作者 Wha Bin Im Yariv Donde Larry A Wheeler 《World Journal of Gastroenterology》 SCIE CAS CSCD 2009年第41期5149-5156,共8页
AIM: To investigate EP4-selective agonist effect on indomethacin-induced gastric lesions and on the spontaneous healing of chronic gastric ulcers. METHODS: In a mouse model of gastric bleeding with high dose of indo... AIM: To investigate EP4-selective agonist effect on indomethacin-induced gastric lesions and on the spontaneous healing of chronic gastric ulcers. METHODS: In a mouse model of gastric bleeding with high dose of indomethacin (20 mg/kg), an EP4-selective agonist was administered orally. Stomach lesions and gastric mucous regeneration were monitored. In a mouse model of chronic gastric ulcer induced by acetic acid, EP4 agonist effect on the healing of chronic gastric ulcer was evaluated in the presence or absence of low dose indomethadn (3 mg/kg). In cultured human gastric mucous cells, EP4 agonist effect on indomethacin- induced apoptosis was assessed by flow cytometry. RESULTS: The EP4-selective agonist reduced high dose indomethacin-induced acute hemorrhagic damage and promoted mucous epithelial regeneration. Low-dose indomethacin aggravated ulcer bleeding and inflammation, and delayed the healing of the established chronic gastric ulcer. The EP4 agonist, when applied locally, not only offset indomethacin-induced gastric bleeding and inflammation, but also accelerated ulcer healing. In the absence of indomethacin, the EP4 agonist even accelerated chronic gastric ulcer healing and suppressed inflammatory cell infiltration in the granulation tissue. In vitro, the EP4 agonist protected human gastric mucous cells from indomethacin-induced apoptosis.CONCLUSION: EP4-selective agonist may prevent indomethacin-induced gastric lesions and promote healing of existing and i ulcers, via promoting mucous epithelial cells. proliferation and survival of mucous epithelial cells. 展开更多
关键词 Prostaglandin E2 Non-steroidal anti-inflam- matory drugs Gastric bleeding Gastric ulcer EP4- subtype receptor
下载PDF
Mechanism of "Epimedium-Cistanche deserticola" in the treatment of breast cancer with bone metastasis
12
作者 Yun Mao Xue-Lei Chu +4 位作者 Peng Xue Lin-Lu Li Yi-Xin Su Sheng-Qi He Shi-Jie Zhu 《Journal of Hainan Medical University》 2020年第4期19-25,共7页
Objective:"Epimedium - Cistanche deserticola" is a kind of kidney tonifying drug commonly used in the treatment of breast cancer bone metastasis, which has good clinical effect, but the pharmacological mecha... Objective:"Epimedium - Cistanche deserticola" is a kind of kidney tonifying drug commonly used in the treatment of breast cancer bone metastasis, which has good clinical effect, but the pharmacological mechanism has not been fully clarified. Methods: In this study, the network pharmacology and bioinformatics technology were used to explore the mechanism of "Epimedium - Cistanche deserticola" in the treatment of breast cancer bone metastasis. TCMSP, TCM database@Taiwan and TCMID databases were used to screen the main effective components of the drug. Swiss Target Prediction and STITCH databases were used to search the potential target of action of Epimedium and Cistanche deserticola. Genecards, OMIN and Drugbank databases were used to search the cause of bone metastasis of breast cancer. The target of action of the drug and the disease gene were mapped for GO and KEGG signal pathway analysis, A visualized network of "drug - component - target - signaling pathway" was constructed by using the software of Cytoscape 3.6.0, and the core genes were screened out. Results: The study found that there are 30 main effective components of Epimedium and Cistanche deserticola, and 544 genes are involved in the potential therapeutic targets, among which 101 genes are potential targets of Epimedium and Cistanche deserticola in the treatment of breast cancer bone metastasis. Through the analysis of GO and KEGG pathways, we found that the mechanisms involved in antitumor, osteoblast differentiation, osteoclast apoptosis and regulation of bone microenvironment, such as apoptosis, osteoclast differentiation, PI3K-Akt, HIF-1 signaling pathway, T cell receptor signaling pathway, etc. TP53, VEGFA, AKT1, EGFR, SRC, CCND1, MAPK3, ESR1 may be the key genes in the treatment of breast cancer bone metastasis. Conclusion: In this study, the network of "drug - component - target- signaling pathway" was constructed through network pharmacology, and it was found that the mechanism of "Epimedium - Cistanche deserticola" in the treatment of breast cancer bone metastasis involves multiple targets and pathways, which is conducive to guiding clinical medication. 展开更多
关键词 Bone METASTASIS of BREAST cancer Network PHARMACOLOGY "Epimedium - CISTANCHE deserticola" drug pair MECHANISM of action
下载PDF
肾素-血管紧张素-醛固酮系统的肾脏保护效应
13
作者 余国膺 《中国心脏起搏与心电生理杂志》 2006年第4期284-284,共1页
关键词 肾素-血管紧张素-醛固酮系统 末期肾脏疾病 保护效应 LANCET ALLHAT Effect review drugS RENAL ACE-I
下载PDF
美国FDA就环氧化酶-2抑制剂和非甾体类抗炎药物作出重要决定
14
作者 黄琳 《上海医药》 CAS 2005年第5期230-230,共1页
关键词 非甾体类抗炎药物 环氧化酶-2抑制剂 美国FDA 环氧化酶-2(COX-2) 美国食品和药品管理局 胃肠道不良反应 药品安全使用 2005年 drugs 非选择性 药物相关 消费者 非处方 说明书 类药物 可能性 心血管
下载PDF
基于合规要求探讨药品批发企业不合格药品退货及处置策略
15
作者 张艳 邢倩 +3 位作者 侯玉磊 李海峰 王帅 谢纪珍 《食品与药品》 CAS 2024年第5期479-480,I0004,I0005,共4页
药品批发企业实际经营过程中,不合格药品的退货及处置对企业药品质量管理体系和合规要求提出挑战,本文通过分析不合格药品分类、不合格药品产生原因及法规要求,对不同情况的不合格药品退货处置提出相应建议,最大程度地降低药品在流通过... 药品批发企业实际经营过程中,不合格药品的退货及处置对企业药品质量管理体系和合规要求提出挑战,本文通过分析不合格药品分类、不合格药品产生原因及法规要求,对不同情况的不合格药品退货处置提出相应建议,最大程度地降低药品在流通过程中的风险隐患,提高药品批发企业质量管理效率,助力医药流通行业高质量健康发展。 展开更多
关键词 药品批发企业 不合格药品 药品退货及处置 合规要求
下载PDF
医院病区药房退药原因分析及其应对策略
16
作者 胡敏 郭敬茜 《中国现代药物应用》 2024年第3期151-154,共4页
目的探究医院病区药房退药原因及其应对策略。方法回顾性分析1500张病区药房退药单,分析退药的原因,提出对应的解决措施。结果1500张退药单的退药原因:药品不良反应(23.73%)占首位,其次为患者依从性差(23.00%)、患者出院退药(10.40%)以... 目的探究医院病区药房退药原因及其应对策略。方法回顾性分析1500张病区药房退药单,分析退药的原因,提出对应的解决措施。结果1500张退药单的退药原因:药品不良反应(23.73%)占首位,其次为患者依从性差(23.00%)、患者出院退药(10.40%)以及药房原因(9.67%)等。1500张退药单的退药种类:抗感染类药物(29.07%)占首位,其次为消化系统类药物(23.33%)、解热镇痛类药物(23.00%)以及心血管系统类药物(9.93%)等。1500张退药单的退药科室:肿瘤内科一病区(15.20%)占首位,其次为急诊重症加强护理病房(EICU)(11.73%)、肿瘤内科二病区(9.93%)以及重症加强护理病房(ICU)(8.07%)等。1500张退药单的退药时间:2022年11月~2023年3月退药单数量(30.40%)占首位,对比2021年3~7月份退药单数量(9.93%)升高;2021年8~12月退药单数量(22.47%)多于2022年1~5月(14.53%)。结论经过对医院病区药房的退药原因进行分析,退药的原因与患者自身、医师、护理人员以及药师等相关,故对其采取相应措施,提高护理人员、医师、药师等的专业知识,降低医师对医嘱的下错率,严格从源头对处方进行处理;医院加强对药房的把控力度,使退药的数量明显降低,也降低了医院退药的亏损率;除此之外,对患者的知识面普及也尤为重要,患者的自我意识提升,从而对药物的排斥度降低,进而提高治疗依从性;通过提高退药的制度程序管理,有利于医院加强对药房退药情况的管理,使得流程更加的规范、有序化。 展开更多
关键词 医院病区药房退药 原因分析 应对策略
下载PDF
基于信息系统的住院药品管理模式优化
17
作者 熊子越 徐敏 +3 位作者 许晶晶 何春杨 闵成军 何琴 《中国当代医药》 CAS 2024年第2期137-140,共4页
目的优化住院药品管理模式,提高药品调剂、物流转运、病区退药的工作质量和效率。方法选取2021年5月至8月成都市第三人民医院住院药品管理模式优化前的98776条住院医嘱为对照组,基于信息系统对住院药品调剂、药品物流转运和病区退药的... 目的优化住院药品管理模式,提高药品调剂、物流转运、病区退药的工作质量和效率。方法选取2021年5月至8月成都市第三人民医院住院药品管理模式优化前的98776条住院医嘱为对照组,基于信息系统对住院药品调剂、药品物流转运和病区退药的流程进行优化,选取2022年2月至5月流程优化后的102418条住院医嘱为实验组。比较两组的调剂时间、调剂差错率、配送工人数量以及病区退药率的变化。结果实验组的住院药房总体调剂时间、工人配送时间均短于对照组,调剂差错率为0.05%,低于对照组的0.26%,差异有统计学意义(P<0.05)。流程优化后,病区退药率总体下降78.05%,人力成本节省退药岗位1人,配送工人2人,物力成本约3.5万元/年。结论住院药品管理流程优化有效地降低差错的发生,提高工作效率,保障药品质量和患者的用药安全。 展开更多
关键词 住院药品管理模式 信息系统 住院药品调剂 药品物流转运 病区退药率
下载PDF
我院门诊西药房退药情况分析 被引量:38
18
作者 陈丽 王慧媛 黄佳 《中国药房》 CAS CSCD 北大核心 2006年第21期1620-1621,共2页
目的:总结经验,提高医疗服务质量。方法:对我院门诊西药房2004年11月~2005年3月的患者退药情况进行汇总分析。结果与结论:患者退药有发生药品不良反应、不合理用药、患者拒绝用药等7方面原因,建议医师在开药前应详细询问患者病史... 目的:总结经验,提高医疗服务质量。方法:对我院门诊西药房2004年11月~2005年3月的患者退药情况进行汇总分析。结果与结论:患者退药有发生药品不良反应、不合理用药、患者拒绝用药等7方面原因,建议医师在开药前应详细询问患者病史和药物过敏史,以减少不良反应的发生;对于老年患者和肝功能不良的患者要慎重选药;医院应制定处罚制度,规范医师行为等。 展开更多
关键词 门诊西药房 退药 分析
下载PDF
我院住院西药房退药现状及原因分析 被引量:18
19
作者 徐艳敏 张洪峰 +2 位作者 李倩 李秀清 郭丹丹 《中国医药导报》 CAS 2012年第6期118-120,共3页
目的了解我院住院西药房退药原因并采取有效防范措施,促进医院合理用药,提高药房管理水平。方法收集我院2011年8月住院部西楼药房退药处方580张,以《医疗机构药事管理规定》为依据,从退药科室、退药原因、退药品种数角度进行统计分析并... 目的了解我院住院西药房退药原因并采取有效防范措施,促进医院合理用药,提高药房管理水平。方法收集我院2011年8月住院部西楼药房退药处方580张,以《医疗机构药事管理规定》为依据,从退药科室、退药原因、退药品种数角度进行统计分析并提出建议。结果退药处方最多的科室为小儿内科,共124张,占21.4%,其次为神经内三科,共107张,占18.4%;退药金额最多的是放疗科,共26 769.564元,占28.9%;退药原因中的关键因素是医师原因。结论医院应加强管理,制订严格的退药制度,引入奖惩制度,从医师、药师、患者三方面入手,加强其沟通,严格退药手续,防止因退药造成的医疗差错,同时应强化医生合理用药意识,提高合理用药水平,完善医德教育,从而有效控制退药。 展开更多
关键词 住院西药房 退药 原因 分析 建议
下载PDF
住院药房退药的过程管理 被引量:13
20
作者 冯凌 张梅玲 +2 位作者 丁怡 张玉梅 蔡溱 《药学服务与研究》 CAS CSCD 2013年第4期300-303,共4页
目的:运用过程管理方法规范病区退药,减少出门后退药,保证药品质量。方法:分析和比较第二军医大学长海医院住院药房退药流程优化前(2012年第一季度)和优化后(2013年第一季度)的退药情况。结果:2012年第一季度退药2 466例(0.9%),其中出... 目的:运用过程管理方法规范病区退药,减少出门后退药,保证药品质量。方法:分析和比较第二军医大学长海医院住院药房退药流程优化前(2012年第一季度)和优化后(2013年第一季度)的退药情况。结果:2012年第一季度退药2 466例(0.9%),其中出门前退药592例(24.0%),出门后退药1 874例(76.0%)。2013年第一季度退药1 282例(0.8%),其中出门前退药607例(47.3%),出门后退药675例(52.7%)。经χ2检验分析,2012年第一季度与2013年同期出门前、出门后退药例次有非常显著性差异(P<0.01)。结论:过程管理应用于病区退药管理,有效提高了药房药品质量管理水平,有助于人员综合素质的培养,值得推广。 展开更多
关键词 过程管理 退药管理 住院药房
下载PDF
上一页 1 2 8 下一页 到第
使用帮助 返回顶部